SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: EX-4.5
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea026681201ex4-5_synergy.htm

Chunk 17 of 29
Word Count: 1137
Character Count: 7058

Document Content:

or may limit the right of the Holders of a majority in aggregate Principal amount of the Securities of such series to waive such an Event of Default; or (i) to make any change so long as no Securities are Outstanding. The Trustee is hereby authorized to join with the Issuer in the execution of any such supplemental indenture, to make any further appropriate agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any property thereunder, but the Trustee shall not be obligated to enter into any such supplemental indenture which affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise. Any supplemental indenture authorized by the provisions of this section may be executed without the consent of the Holders of any of the Securities at the time outstanding, notwithstanding any of the provisions of Section 7.02.

Section 7.02 Supplemental
Indentures With Consent of Securityholders. With the consent (evidenced as provided in Article 6) of the Holders of not less than
a majority in aggregate Principal amount of the Securities at the time Outstanding of all series affected by such supplemental indenture
(voting as one class), the Issuer, when authorized by a resolution of its Board of Directors, and the Trustee may, from time to time and
at any time, enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any
manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights
of the Holders of the Securities of each such series; provided, that no such supplemental indenture shall without the consent of each
Holder affected thereby:

(a) change the stated
maturity of the Principal of, or the time of payment of any installment of interest on, such Holder’s Security;

(b) reduce the Principal
thereof or the rate of interest thereon, or any premium payable with respect thereto;

(c) change any place
of payment where, or the currency in which, any Security or any premium or the interest thereon is payable;

(d) change the provisions
for calculating any redemption or repurchase price, including the definitions relating thereto;

(e) make any change
to Section 4.07 or Section 4.10 (except to include other provisions subject to Section 4.10);

(f) reduce the percentage
in Principal amount of outstanding Securities of the relevant series the consent of whose Holders is required for any such supplemental
indenture, for any waiver of compliance with any provisions of this Indenture or any defaults and their consequences provided for in this
Indenture;

(g) alter or impair
the right to convert any Security at the rate and upon the terms provided in Article 12;

(h) waive a default
in the payment of Principal of or interest on any Security of such Holder (except pursuant to a rescission of acceleration pursuant to
Section 4.01);

(i) adversely affect
the rights of such Holder under any mandatory redemption or repurchase provision or any right of redemption or repurchase at the option
of such Holder;

(j) modify any of
the provisions of this Section 7.02, except to increase any such percentage or to provide that certain other provisions of this Indenture
cannot be modified or waived without the consent of the Holder of each outstanding Security affected thereby; or

(k) change or waive
any provision that, pursuant to a board resolution or indenture supplemental hereto establishing the terms of one or more series of Securities,
is prohibited to be so changed or waived.

Upon the written request of
the Issuer, accompanied by a copy of a resolution of the Board of Directors certified by the secretary or an assistant secretary of the
Issuer authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of
Securityholders as aforesaid and other documents, if any, required by Section 6.01, the Trustee shall join with the Issuer in the execution
of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this
Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture.

It shall not be necessary
for the consent of the Securityholders under this section to approve the particular form of any proposed supplemental indenture, but it
shall be sufficient if such consent shall approve the substance thereof.

Promptly after the execution
by the Issuer and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Issuer shall mail a notice
thereof by first class mail to the Holders of Securities of each series affected thereby at their addresses as they shall appear on the
registry books of the Issuer, setting forth in general terms the substance of such supplemental indenture. Any failure of the Issuer to
mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.

Section 7.03 Effect of
Supplemental Indenture. Upon the execution of any supplemental indenture pursuant to the provisions hereof, this Indenture shall be
and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties
and immunities under this Indenture of the Trustee, the Issuer and the Holders of Securities of each series affected thereby shall thereafter
be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions
of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.

Section 7.04 Documents
to Be Given to Trustee. The Trustee, subject to the provisions of Section 5.01 and Section 5.02, may receive an Officers’ Certificate
and an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article 7 complies with the
applicable provisions of this Indenture.

Section 7.05 Notation on
Securities in Respect of Supplemental Indentures. Securities of any series authenticated and delivered after the execution of any
supplemental indenture pursuant to the provisions of this Article may bear a notation in form approved by the Trustee for such series
as to any matter provided for by such supplemental indenture or as to any action taken at any such meeting. If the Issuer or the Trustee
shall so determine, new Securities of any series so modified as to conform, in the opinion of the Trustee and the Board of Directors,
to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Issuer, authenticated by the
Trustee and delivered in exchange for the Securities of such series then outstanding.

Article

CONSOLIDATION,
MERGER, SALE OR CONVEYANCE